• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素对酒渣鼻的意外控制作用

Incidental control of rosacea by somatostatin.

作者信息

Piérard-Franchimont Claudine, Quatresooz Pascale, Piérard Gérald E

机构信息

Department of Dermatopathology, University Medical Center of Liège, Belgium.

出版信息

Dermatology. 2003;206(3):249-51. doi: 10.1159/000068898.

DOI:10.1159/000068898
PMID:12673083
Abstract

BACKGROUND

The precise pathomechanism of rosacea remains elusive. The disease commonly requires long-term treatments using topical or oral therapies.

OBJECTIVE

This report presents incidental findings about the possible modulatory role of somatostatin in the outcome of rosacea.

METHOD

Four patients presenting long-standing recalcitrant facial rosacea were treated with octreotide for diabetic retinopathy.

RESULTS

Rosacea improved rapidly and even cleared without any recurrence in 3 of the patients.

CONCLUSION

The beneficial effect might be attributed to inhibitory actions on the sebaceous gland, the neovascularization and/or on the inflammatory process.

摘要

背景

酒渣鼻的确切发病机制仍不清楚。该病通常需要使用局部或口服疗法进行长期治疗。

目的

本报告介绍了关于生长抑素在酒渣鼻病情转归中可能的调节作用的意外发现。

方法

4例患有长期顽固性面部酒渣鼻的患者因糖尿病视网膜病变接受奥曲肽治疗。

结果

3例患者的酒渣鼻迅速改善,甚至完全消退且无复发。

结论

这种有益作用可能归因于对皮脂腺、新血管形成和/或炎症过程的抑制作用。

相似文献

1
Incidental control of rosacea by somatostatin.生长抑素对酒渣鼻的意外控制作用
Dermatology. 2003;206(3):249-51. doi: 10.1159/000068898.
2
[Therapy of diabetic retinopathy with somatostatin analogues].[生长抑素类似物治疗糖尿病视网膜病变]
Ophthalmologe. 2004 Mar;101(3):290-3. doi: 10.1007/s00347-003-0903-2.
3
Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.
Horm Metab Res. 2001 May;33(5):300-6. doi: 10.1055/s-2001-15282.
4
Use of long-acting somatostatin analogue treatment in diabetic retinopathy.
Dev Ophthalmol. 2007;39:111-121. doi: 10.1159/000098503.
5
The potential role of octreotide in the treatment of diabetic retinopathy.奥曲肽在糖尿病视网膜病变治疗中的潜在作用。
Treat Endocrinol. 2005;4(4):199-203. doi: 10.2165/00024677-200504040-00001.
6
[Pharmacological treatment of diabetic retinopathy].[糖尿病视网膜病变的药物治疗]
Ophthalmologe. 2004 Dec;101(12):1165-70. doi: 10.1007/s00347-004-1141-y.
7
Pharmacological treatment of diabetic retinopathy.糖尿病视网膜病变的药物治疗。
Ophthalmologica. 2007;221(2):112-7. doi: 10.1159/000098256.
8
Somatostatin in diabetic retinopathy.糖尿病视网膜病变中的生长抑素。
Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:518-24.
9
The role of modulation of GH/IGF-I axis in the development of diabetic proliferative retinopathy.
J Endocrinol Invest. 2003;26(8 Suppl):114-6.
10
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.15%壬二酸凝胶与0.75%甲硝唑凝胶局部治疗丘疹脓疱型玫瑰痤疮的比较:一项随机试验的结果
Arch Dermatol. 2003 Nov;139(11):1444-50. doi: 10.1001/archderm.139.11.1444.

引用本文的文献

1
Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea.基于羟丙基壳聚糖和辛酰甘氨酸钾的新产品治疗酒渣鼻的临床和仪器评估。
J Cosmet Dermatol. 2012 Mar;11(1):37-41. doi: 10.1111/j.1473-2165.2011.00598.x.